Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Open in API
Filings indexed 746 across all filing types
Latest filing 2026-06-03 Share Issue/Capital Cha…
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
S-8 POS
Share Issue/Capital Change Classification · 87% confidence The document is a Post-Effective Amendment No. 1 to Form S-8 (Registration Statement No. 333-…), filed with the SEC to register additional common shares under the company’s equity incentive plan. Form S-8 is used to register share issuances under employee benefit and equity plans, which constitutes a change in the company’s capital structure (new shares being registered for issuance). This is not an earnings release, management discussion, or proxy material, but rather a primary registration statement to effect a share issuance. Therefore, the correct classification is Share Issue/Capital Change (SHA).
2026-06-03 English
S-8 POS
Share Issue/Capital Change Classification · 86% confidence The document is a Post-Effective Amendment No.1 to Form S-8 filed under the Securities Act of 1933. Form S-8 is used to register shares for issuance under an employee equity incentive plan, representing a change in the company’s capital structure by adding registered shares available for issuance. This is clearly about new share issues/capital changes rather than repurchases or proxy materials. Accordingly, it fits the definition of Share Issue/Capital Change (SHA).
2026-06-03 English
S-8 POS
Share Issue/Capital Change Classification · 90% confidence The document is a post-effective amendment to a Form S-8 registration statement, detailing the registration of common shares to be issued under an equity incentive plan and related share authorization figures. Form S-8 relates to the issuance of new shares under employee benefit plans, representing a capital change/issuance event rather than an annual report, earnings release, or other categories. This fits the definition of a Share Issue/Capital Change announcement.
2026-06-03 English
S-8 POS
Share Issue/Capital Change Classification · 90% confidence The document is a Post-Effective Amendment No. 1 to multiple Form S-8 registration statements filed with the SEC, which registers common shares for issuance under the company’s equity incentive plans. Form S-8 filings and their amendments relate directly to the registration of new shares for employee benefit plans, constituting a capital change/share issuance. Therefore, the correct category is Share Issue/Capital Change (SHA).
2026-06-03 English
S-8 POS
Share Issue/Capital Change Classification · 90% confidence The document is a Form S-8 Post-Effective Amendment filing with the SEC to register shares under the company’s equity incentive plan. Form S-8 is used to register new issuances of shares under employee plans, which constitutes a capital change/share issuance. This aligns with the “Share Issue/Capital Change” category (SHA).
2026-06-03 English
S-8 POS
Share Issue/Capital Change Classification · 90% confidence The document is a Post-Effective Amendment No. 1 to a Form S-8 registration statement filed with the SEC. Form S-8 is used to register securities (common shares) to be issued under an equity incentive plan. This is not an earnings release, 10-K, proxy, or other management report, but rather a securities registration for new share issuance under the company’s equity plan. This falls under our “Share Issue/Capital Change” category.
2026-06-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.